Oncotarget
By Oncotarget Podcast
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Oncotarget Podcast
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 500
Description
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed.
Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/
| Episode | Date |
|---|---|
|
DUSP5 Feedback Linked to Limited Therapeutic Potential of DUSP4 in Colorectal Cancer
|
Nov 10, 2026 |
|
Multi-Kinase Inhibitor Temporarily Delays Ewing Sarcoma Growth in Preclinical Model
|
Nov 04, 2026 |
|
Coagulation-Related Genes and Tumor Location Linked to Lung Cancer Survival
|
Nov 04, 2026 |
|
International Tumor Board Explores Personalized Treatment Strategies for Colon Cancer Without Measurable Disease
|
Oct 26, 2026 |
|
International Tumor Board Explores Personalized Treatment Options for Glioblastoma With MDM2 and EGFR Amplifications
|
Oct 22, 2026 |
|
Molecular Tumor Board Maps Precision Treatment Options for a Woman With Multiple Primary Cancers
|
Oct 20, 2026 |
|
Pan-Cancer Analysis Identifies Buckwheat-Derived Compound as Potential AKT1 Drug-Design Candidate
|
Oct 14, 2026 |
|
Epigenetic Silencing of TRAIL-R2 Is Linked to Aggressive Features in Breast Cancer
|
Oct 06, 2026 |
|
Gut Microbiome Emerges as a Potential Partner in Precision Cancer Therapy
|
Sep 28, 2026 |
|
DHHC3 Helps Melanoma Tumors Evade Antitumor Immunity
|
Sep 23, 2026 |
|
Commentary Calls for Consistent Evaluation of Potential Links Between COVID-19, Vaccination and Cancer
|
Sep 17, 2026 |
|
Restoring MHC-I Expression Could Strengthen Immune Responses Against CNS Cancers
|
Sep 09, 2026 |
|
Therapeutic HPV Vaccine PepCan Tested for Preventing Head and Neck Cancer Recurrence
|
Sep 08, 2026 |
|
Oncotarget Supports WIN 2026 Symposium Advancing Precision Oncology
|
Sep 08, 2026 |
|
Tumor-Derived Extracellular Vesicles Show Promise for Earlier Detection of Metastatic Risk
|
Sep 01, 2026 |
|
Tumor-Infiltrating Lymphocyte Therapy Offers a Promising Approach for Treating Solid Tumors
|
Aug 31, 2026 |
|
KRAS G12C Mutation Identified as a Rare Potential Target in Genitourinary Cancers
|
Aug 28, 2026 |
|
New Analysis Challenges Methods Used to Measure Residual DNA in mRNA Vaccines
|
Aug 25, 2026 |
|
Experimental Compounds Push Cancer-Promoting Pathways Into Overdrive in Pancreatic Cancer Cells
|
Aug 24, 2026 |
|
Trk and IGF1R-Related Signaling Linked to Delayed Ewing Sarcoma Growth
|
Aug 10, 2026 |
|
CTHRC1 in the Tumor Microenvironment Drives Colorectal Cancer Growth in Mouse Study
|
Aug 10, 2026 |
|
Artificial Intelligence Could Transform Nutrition Care for Cancer Patients
|
Jul 28, 2026 |
|
Molecular Tumor Board Explores Personalized Treatment Strategies for Patient with Multiple Cancers
|
Jul 22, 2026 |
|
Rare Genetic Combination in Gastrointestinal Tumor Offers New Insights Into Precision Cancer Care
|
Jul 13, 2026 |
|
Rare Benign Kidney Tumor Case Highlights Value of Biopsy and Minimally Invasive Treatment
|
Jul 06, 2026 |
|
Targeted Therapies Coincided With Dramatic Decline in Multiple Myeloma Mortality in the US
|
Jun 29, 2026 |
|
TRAIL-R2 Silencing Linked to More Aggressive Breast Cancer
|
Jun 24, 2026 |
|
Protein Linked to Melanoma Growth May Suppress the Body’s Natural Anti-Tumor Immune Response
|
Jun 17, 2026 |
|
PDX1 May Link Metabolic Dysfunction to Prostate Cancer Progression
|
Jun 16, 2026 |
|
HPV Vaccine Shows Safety but Uncertain Benefit in Preventing Head & Neck Cancer Recurrence
|
Jun 15, 2026 |
|
Experimental Compounds Trigger Cancer Cell Death in KRAS-Driven Pancreatic Cancer
|
Jun 08, 2026 |
|
Cancer Care Often Overlooked in Humanitarian Crises
|
Jun 03, 2026 |
|
Protein in Tumor Microenvironment Found to Promote Colorectal Cancer Growth and Immune Evasion
|
Jun 02, 2026 |
|
Immune Checkpoint Inhibitors May Improve Outcomes in High-Risk Solid Tumors
|
May 20, 2026 |
|
Rare Laryngeal Leiomyosarcoma Successfully Treated with Surgery and Adjuvant Chemotherapy
|
May 13, 2026 |
|
Agentic AI Systems May Transform Nutritional Care in Oncology
|
May 11, 2026 |
|
Rare Dual-Mutation GIST Responds to Targeted Therapy, Challenging Established Tumor Biology
|
May 06, 2026 |
|
Mapping the Hidden Structure of Glioma Research: What Are We Missing?
|
May 05, 2026 |
|
Targeted Therapies Drive Long-Term Decline in Multiple Myeloma Mortality in the U.S.
|
Apr 29, 2026 |
|
SCD1 Inhibition Strategy Shows Potent Synergy with Regorafenib and Metformin in Tumor Cell Killing
|
Apr 21, 2026 |
|
Epigenetic Dysregulation of PDX1 Drives Prostate Cancer Progression
|
Apr 15, 2026 |
|
Cancer Care in Conflict Zones Remains Critically Neglected
|
Apr 13, 2026 |
|
Oncotarget Editorial Highlights Advances in Scientific Integrity and Publishing Transparency
|
Apr 10, 2026 |
|
CREB5: A Master Regulator of Stem Cell-Like Programs in Prostate Cancer Progression
|
Apr 07, 2026 |
|
Adjuvant PD-1/PD-L1 Inhibitors Show Efficacy but Highlight Safety Considerations in Solid Cancers
|
Apr 07, 2026 |
|
Bibliometric Mapping Reveals the Evolution of Glioma Classification Research
|
Apr 06, 2026 |
|
The SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Combine to Kill Uveal Melanoma Cells
|
Mar 31, 2026 |
|
Predicting Colorectal Cancer Survival: How Machine Learning Combines Clinical and Biological Clues
|
Mar 25, 2026 |
|
CREB5 Linked to Stem Cell-Like Programs That Promote Prostate Cancer Progression
|
Mar 24, 2026 |
|
Impact Journals to Participate at AACR Annual Meeting 2026 in San Diego
|
Mar 16, 2026 |
|
CAR-T Cell Therapy: A Revolutionary Approach to Cancer Treatment
|
Mar 10, 2026 |
|
mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review
|
Feb 27, 2026 |
|
Next-Generation CAR-T Designs That Could Transform Cancer Treatment
|
Feb 25, 2026 |
|
Researchers Question Editorial Bias in COVID-19 Vaccine Debate
|
Feb 16, 2026 |
|
Case Report Explores Potential Link Between mRNA COVID-19 Vaccines and Cancer
|
Feb 11, 2026 |
|
How HPV and COVID-19 Spike Proteins May Interact to Impact Cancer Suppression
|
Feb 09, 2026 |
|
Exploring Possible Links Between COVID-19 Vaccination, Infection, and Cancer
|
Jan 26, 2026 |
|
Overcoming Aromatase Inhibitor Resistance in Breast Cancer: A New Therapeutic Strategy
|
Jan 13, 2026 |
|
New Hypothesis Links HPV E6 and SARS‑CoV‑2 Spike Proteins to Reduced p53 Activity
|
Jan 13, 2026 |
|
Evaluation of Cancer Reports Following COVID-19 Vaccination and Infection
|
Jan 08, 2026 |
|
Colorectal Cancer Survival Predicted by AI Using Clinical and Molecular Features
|
Dec 17, 2025 |
|
Comprehensive Genomic Profiling in Cancer: Insights from Over 10,000 Tumors
|
Dec 15, 2025 |
|
Repurposing Statins: Exploring Anti-Tumor Effects in Colorectal Cancer
|
Dec 03, 2025 |
|
New Antibody Removes Tregs to Boost Immune Response Against Cancer
|
Nov 19, 2025 |
|
Probiotic Bifidobacterium May Boost Cancer Treatment and Suppress Tumors
|
Nov 18, 2025 |
|
Clinical Trial Participants Call for More Inclusive, Patient-Centered Cancer Research
|
Nov 17, 2025 |
|
Lower LRIG1 Expression Linked to Aggressive Gliomas
|
Nov 12, 2025 |
|
Eco-Friendly Nanoparticles Improve Cidofovir’s Anticancer and Antiviral Effects
|
Nov 10, 2025 |
|
How Low Oxygen Shields Prostate Cancer from Ferroptosis Therapies
|
Nov 06, 2025 |
|
Genetic Study Identifies Potential Diagnostic Marker for Rare Blood Cancer BPDCN
|
Oct 22, 2025 |
|
Folate Receptor Beta Found in Pediatric Tumors May Improve Fluorescence-Guided Cancer Surgery
|
Oct 20, 2025 |
|
New Radiofrequency Therapy Slows Glioblastoma Growth and Targets Tumor Stem Cells
|
Oct 14, 2025 |
|
New Insights into HER2-Mutated Non-Small Cell Lung Cancer in Brazil
|
Oct 08, 2025 |
|
Engineered Bacterial Therapy Activates Immune Response in Cancer Preclinical Studies
|
Oct 08, 2025 |
|
Wafik S. El-Deiry Chairs 2025 WIN Symposium in Collaboration with APM in Philadelphia
|
Oct 01, 2025 |
|
Precision Oncology in Metastatic Colorectal Cancer: A Real-World Case Study
|
Sep 24, 2025 |
|
Loss of Trp53 Gene Promotes Tumor Growth and Immune Suppression in Ovarian Cancer
|
Sep 24, 2025 |
|
Immunotherapy Response in Pancreatic Cancer: What a New Study Reveals
|
Sep 11, 2025 |
|
Blocking Protein Control Pathway Slows Rhabdomyosarcoma Growth in Mice
|
Aug 29, 2025 |
|
Behind the Study: R-spondin Family Roles in Metastatic Prostate Cancer
|
Aug 26, 2025 |
|
Amivantamab Monotherapy in Rare EGFR-Mutated Advanced NSCLC
|
Aug 26, 2025 |
|
Aramchol Boosts Regorafenib Effectiveness in Gastrointestinal Tumors
|
Aug 19, 2025 |
|
FDA-Approved MI Cancer Seek Test Enhances Tumor Profiling for Precision Oncology
|
Aug 15, 2025 |
|
New Compound Disrupts Survival Pathways in Aromatase Inhibitor-Resistant Breast Cancer Cells
|
Aug 12, 2025 |
|
Cigarette Smoke and Weak DNA Repair: A Double Hit Behind Lung Cancer Risk
|
Aug 11, 2025 |
|
New Gene Linked to Aggressive, Treatment-Resistant Prostate Cancer
|
Aug 11, 2025 |
|
A New Way to Target Resistant Prostate Cancer Cells
|
Jul 29, 2025 |
|
Comprehensive Genomic Testing Reveals Treatment Targets in 90% of Advanced Solid Tumors
|
Jul 29, 2025 |
|
Blood Filtration Stabilizes Advanced Pancreatic Cancer: A Case Report
|
Jul 24, 2025 |
|
Cholesterol-Lowering Drugs Show Promise Against Colorectal Cancer
|
Jul 22, 2025 |
|
microRNAs Emerge as Biomarkers and Diagnostic Tools in Soft Tissue Sarcoma
|
Jul 18, 2025 |
|
New Antibody Selectively Targets Immune Cells That Suppress Anti-Tumor Responses
|
Jul 16, 2025 |
|
PRDX1 Identified as Key to Chemotherapy Resistance in Cancer Cells
|
Jul 14, 2025 |
|
Prostate Cancer Cells Survive Treatment by Storing Fat in Low Oxygen Conditions
|
Jul 14, 2025 |
|
EGFR-Targeted Therapy Resistance in Breast and Head & Neck Cancers
|
Jul 09, 2025 |
|
Key Genetic Alterations and Biomarker for Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Jul 07, 2025 |
|
Immunotherapy Safety for Hepatocellular Carcinoma in Latin America: Insights from a Real-World Study
|
Jul 02, 2025 |
|
New Drug Combination Redefines First-Line Treatment for Advanced Urothelial Cancer
|
Jul 01, 2025 |
|
HER2-Mutated NSCLC in Brazil Shows Diverse Genetic Patterns and Treatment Gaps
|
Jun 27, 2025 |
|
WIN International Molecular Tumor Board Recommends Tailored Treatment for Advanced Colorectal Cancer
|
Jun 24, 2025 |
|
CHEK2 Identified as a Potential Target to Improve Immunotherapy in Solid Tumors
|
Jun 20, 2025 |
|
Rare Pancreatic Cancer Patients Show Strong Response to Immunotherapy
|
Jun 17, 2025 |
|
Exploring a Combined Approach: Radiation and Immunotherapy in Bladder Cancer
|
Jun 16, 2025 |
|
Balancing Time, Cost, and Quality in Cardio-Oncology Care
|
Jun 13, 2025 |
|
Rare Non-Small Cell Lung Cancer with Brain Metastases Responds to Amivantamab Monotherapy
|
Jun 11, 2025 |
|
Oncotarget Sponsors Open Access Team in 2025 Ride for Roswell
|
Jun 10, 2025 |
|
Cigarette Smoke and DNA Repair Deficiency Drive Lung Cancer Development
|
Jun 09, 2025 |
|
Experimental Triple Therapy Improves Survival in Glioblastoma Mouse Model
|
Jun 04, 2025 |
|
Targeting PCNA-Androgen Receptor Interaction Suppresses Prostate Cancer Cell Growth
|
Jun 04, 2025 |
|
Blocking PRDX1 Protein May Improve Chemotherapy Response in Ovarian Cancer
|
Jun 03, 2025 |
|
Immune Side Effects of Liver Cancer Therapy Studied in Latin American Patients
|
May 23, 2025 |
|
Engineered Proteins Show Promise in Stopping Glioblastoma Invasion
|
May 21, 2025 |
|
Combining Radiation and Immunotherapy Shows Promise for Bladder Cancer
|
May 21, 2025 |
|
New Ultra-Sensitive DNA Blood Test for Detecting Residual Cancer in B-cell Lymphoma Patients
|
May 19, 2025 |
|
Blood Type A Identified as Potential Breast Cancer Risk Factor
|
May 14, 2025 |
|
METTL3 Drives Oral Cancer by Blocking Tumor-Suppressing Gene
|
May 09, 2025 |
|
Panitumumab & Low-Dose Capecitabine: Promising Maintenance Therapy for Metastatic Colorectal Cancer
|
May 07, 2025 |
|
Oncotarget Participation at SSP 2025 Annual Meeting
|
May 05, 2025 |
|
Early Immune Evasion Found in HPV-Related Pre-Cancer Lesions of the Anogenital Region
|
Apr 28, 2025 |
|
New Insights into p53: A Powerful Gene’s Role in Cancer Therapy
|
Apr 22, 2025 |
|
Gene Variant Linked to Benign Prostate Hyperplasia Risk in Lebanese Men
|
Apr 15, 2025 |
|
Protein GSK3β Offers New Angle on Overcoming Melanoma Drug Resistance
|
Apr 11, 2025 |
|
Targeting SETDB1: A New Strategy for Treating Osteosarcoma
|
Apr 09, 2025 |
|
AI That Measures Its Own Uncertainty Could Improve Liver Cancer Detection
|
Apr 05, 2025 |
|
Triple Therapy Slows Glioblastoma Growth and Extends Survival in Preclinical Study
|
Apr 03, 2025 |
|
Single Protein Mimics Retinoic Acid Therapy to Help Leukemia Cells Mature
|
Mar 26, 2025 |
|
When the Cure Becomes the Cause: A Rare Case of Cancer from Donor Cells
|
Mar 25, 2025 |
|
NSD2 Gene Drives Cancer Cell Identity in Multiple Myeloma
|
Mar 25, 2025 |
|
Why Some Breast Cancer Treatments Stop Working
|
Mar 24, 2025 |
|
Clear Scans Can Be Misleading: Residual Cancer Linked to Worse Outcomes
|
Mar 20, 2025 |
|
WIN Consortium Leading the Future of Precision Cancer Medicine
|
Mar 15, 2025 |
|
Oncotarget to Participate at the AACR Annual Meeting 2025
|
Mar 12, 2025 |
|
Rethinking Breast Cancer Screening: New Insights on Overdiagnosis
|
Mar 11, 2025 |
|
A Rare Genetic Shift That Helped Lung Cancer Evade Treatment
|
Mar 11, 2025 |
|
How Environmental Exposures Affect Genes and Increase Cancer Risk
|
Mar 08, 2025 |
|
Engineered TIMP Molecules Show Potential to Slow Glioblastoma Brain Cancer Spread
|
Mar 02, 2025 |
|
How a Simple Blood Test Could Predict Colorectal Cancer Surgery Success
|
Feb 25, 2025 |
|
Researchers Identify New p53 Targets to Combat Cancer Growth
|
Feb 22, 2025 |
|
Innovative Biomaterial Accelerates Healing of Chemotherapy-Induced Oral Ulcers in Animal Model
|
Feb 21, 2025 |
|
Panitumumab with Low-Dose Capecitabine as a Maintenance Regimen: A Viable Option?
|
Feb 18, 2025 |
|
SETDB1 Amplification Identified as a Potential Target for New Osteosarcoma Treatment
|
Feb 13, 2025 |
|
HER2-Low Breast Cancer: A New Understanding
|
Feb 12, 2025 |
|
Rare Case of Donor Cell-Derived Blood Cancer Discovered Nine Years After Stem Cell Transplant
|
Feb 10, 2025 |
|
New Genetic Mutation Linked to Drug Resistance in Non-Small Cell Lung Cancer Patient
|
Feb 06, 2025 |
|
A New Approach for Cancer Treatment: The Surprising Relationship Between KLRG1 and PD-1
|
Jan 28, 2025 |
|
Tracking cfDNA Release Dynamics During Colorectal Cancer Surgery
|
Jan 27, 2025 |
|
HER2-Low Breast Cancer: Genomic Insights and Evolving Treatment Paradigms
|
Jan 22, 2025 |
|
Anti-Correlation Between KLRG1 and PD-1 in Tumor CD8 T Cells
|
Jan 21, 2025 |
|
Mastocytosis: Key Insights into KIT M541L Gene Mutation
|
Jan 15, 2025 |
|
The Hidden Risks of At-Home Genetic Cancer Tests
|
Jan 03, 2025 |
|
Pitfalls of FDA-Approved Germline Cancer Predisposition Tests
|
Dec 30, 2024 |
|
A New Path to Tumor Suppression: The Promise of PG3
|
Dec 18, 2024 |
|
Breakthroughs in Cell-Penetrating Monoclonal Antibody Therapies
|
Dec 11, 2024 |
|
CT Radiomics and Body Composition for Predicting Hepatic Decompensation
|
Dec 09, 2024 |
|
Small Cell Lung Cancer: Advancing Precision Medicine with Biomarker Research
|
Dec 04, 2024 |
|
B7-H4 as a Therapeutic Target in Adenoid Cystic Carcinoma
|
Dec 04, 2024 |
|
Mesenchymal Stem Cells in Cancer Immunotherapy: Promises and Challenges
|
Dec 03, 2024 |
|
Persistence Landscapes: A Path to Unbiased Radiological Interpretation
|
Nov 27, 2024 |
|
Visualizing Radiological Data Bias with Persistence Images
|
Nov 25, 2024 |
|
Persistence Barcodes: Reducing Bias in Radiological Analysis
|
Nov 20, 2024 |
|
Behind the Study: DLL3, ASC1, TTF-1 & Ki-67 in Precision Medicine for SCLC
|
Nov 18, 2024 |
|
Reducing Bias in Radiology with Topological Data Analysis
|
Nov 18, 2024 |
|
Cancer Dormancy and Tumor Recurrence: New Insights for Breast Cancer
|
Nov 13, 2024 |
|
Extracellular Matrix and Tumor-Immune Interactions: Challenges & Opportunities
|
Nov 12, 2024 |
|
Navigating Bias in AI-Driven Cancer Detection
|
Nov 11, 2024 |
|
Precision Medicine in SCLC: DLL3, ASC1, TTF-1, and Ki-67 Expression
|
Nov 06, 2024 |
|
Immunotherapy Success in KRAS G12C Adenosquamous Pancreatic Cancer
|
Nov 04, 2024 |
|
Tumor Dormancy Initiated by Lymphovascular Embolus
|
Oct 30, 2024 |
|
Complete Response to Encorafenib + Binimetinib in BRAF V600E-Mutant Tumor
|
Oct 29, 2024 |
|
Behind the Study: Molecular Chaperones & Tumor Suppressor Stability
|
Oct 24, 2024 |
|
Next-Generation Antibodies for Cancer Therapy
|
Oct 24, 2024 |
|
How Blood Cancer Cells Rewire to Evade Drug Treatment
|
Oct 23, 2024 |
|
Tribute to Dr. Mikhail (Misha) Blagosklonny
|
Oct 22, 2024 |
|
Next-Gen Cell-Penetrating Antibodies for Tumor Targeting and RAD51 Inhibition
|
Oct 21, 2024 |
|
Molecular Chaperones: Guardians of Tumor Suppressor Stability
|
Oct 16, 2024 |
|
TP53 Mutated AML: Transplant or No Transplant
|
Oct 11, 2024 |
|
Targeting Stem Cell-like Traits: How miR-10b Inhibition Treats Metastatic Breast Cancer
|
Oct 11, 2024 |
|
Zika Virus as a Treatment for Brain Cancer: A Systematic Review
|
Oct 09, 2024 |
|
Lessons from ACDC-RP Trial: Designing Neoadjuvant Therapy Trials for Prostatectomy
|
Oct 07, 2024 |
|
Key Roles of MIF, DDT, and CD74 in Melanoma Prognosis and Therapy
|
Aug 28, 2024 |
|
miR-10b Inhibition: A Strategy for Treating Metastatic Breast Cancer
|
Aug 28, 2024 |
|
Artificial Intelligence: Revolutionizing Precision Oncology
|
Aug 27, 2024 |
|
Genotype Matters: Tailored Screening for Germline CHEK2 Variants
|
Aug 26, 2024 |
|
Disrupting NKG2A:HLA-E Interactions for Enhanced Anti-Cancer Immunity
|
Aug 21, 2024 |
|
Role of the Gut Barrier in Colorectal Cancer Treatment
|
Aug 19, 2024 |
|
Nanobody Inhibits Metastasis of Breast Tumor Cells to Lung in Mice
|
Aug 15, 2024 |
|
Response of BRAF-Mutated Spindle Cell Sarcoma to BRAF/MEK Inhibitors
|
Aug 14, 2024 |
|
New Directions in Targeting the Multifaceted BRAF in Cancer
|
Aug 12, 2024 |
|
Combining Regorafenib and TAS102 to Target Gastrointestinal Cancers and Overcome Cancer Stemness
|
Aug 09, 2024 |
|
TCR CDR3s and Renalase-1 Linked to Increased Melanoma Survival
|
Aug 08, 2024 |
|
Dealing with Runaway Metastatic Disease
|
Aug 07, 2024 |
|
INT-1B3 miR-193a-3p Mimic Boosts T Cell Immunity and Induces Tumor Cell Death
|
Aug 05, 2024 |
|
Prognostic and Therapeutic Insights Into MIF, DDT, and CD74 in Melanoma
|
Jul 26, 2024 |
|
Novel Triple-Drug Combination to Fight Pancreatic Cancer
|
Jul 25, 2024 |
|
Prevalence and Impact of the KIT M541L Variant in Patients with Mastocytosis
|
Jul 24, 2024 |
|
Oncotarget Welcomes New Editorial Board Members
|
Jul 22, 2024 |
|
Efficacy of Pembrolizumab with sEphB4-HSA in HPV-negative EphrinB2-positive HNSCC
|
Jul 22, 2024 |
|
DDX41’s Unique Contribution to Myeloid Leukemogenesis
|
Jul 19, 2024 |
|
Using Early On-treatment ctDNA Measurements as Response Assessment in mCRPC
|
Jul 17, 2024 |
|
HER2-low and HER2-zero in Breast Cancer Between Prognosis, Prediction and Entity
|
Jul 16, 2024 |
|
Comparison of FDG-PET/CT and CT for Treatment Evaluation of Patients With Unresectable Mesothelioma
|
Jul 15, 2024 |
|
AI for Improved PET/CT Attenuation Correction in Prostate Cancer Imaging
|
Jul 11, 2024 |
|
Targeting ABC Transporters in PDAC – Past, Present, or Future?
|
Jul 10, 2024 |
|
Regorafenib Synergizes With TAS102 Against Multiple Gastrointestinal Cancers
|
Jul 08, 2024 |
|
Editorial: Genomics Has More to Reveal
|
Jul 02, 2024 |
|
Starving Cancer Cells to Enhance DNA Damage and Immunotherapy Response
|
Jun 26, 2024 |
|
Leveraging Gold Nanostars for Precision Laser Interstitial Thermal Therapy
|
Jun 24, 2024 |
|
Impact of Dual Immunotherapies Before Surgery in HR+/HER2-negative Breast Cancer
|
Jun 20, 2024 |
|
Assessment of CEA, CA-125, and CA19-9 as Adjuncts in Non-small Cell Lung Cancer Management
|
Jun 19, 2024 |
|
When Does a Melanoma Metastasize? Implications for Management
|
Jun 18, 2024 |
|
Impact Journals Sponsors 2024 Ride for Roswell
|
Jun 11, 2024 |
|
Dr. Blagosklonny’s Strategy: From Osimertinib to Preemptive Combinations
|
Jun 06, 2024 |
|
Synergistic Cytotoxicity of HDAC and PARP Inhibitors and Decitabine in Pancreatic Cancer Cells
|
Jun 05, 2024 |
|
BTK Inhibitor-related Cardiotoxicity: Quest for Predictive Biomarkers, Improved Risk Stratification
|
Jun 04, 2024 |
|
Behind the Study: Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167
|
May 29, 2024 |
|
The Importance of Integrated Therapies on Cancer: Silibinin, an Old and New Molecule
|
May 28, 2024 |
|
Combating Doxorubicin-Resistant Acute Myeloid Leukemia
|
May 23, 2024 |
|
GZ17-6.02 Kills Uveal Melanoma Cells
|
May 22, 2024 |
|
Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167 via EMT and Antiviral Immune Response
|
May 20, 2024 |
|
Expression of Cyclin D1 in Penile Cancer
|
May 15, 2024 |
|
Oncotarget at SSP 46th Annual Meeting
|
May 13, 2024 |
|
SARS-CoV-2 Spike Protein Disrupts p53 Tumor Suppressor Pathway
|
May 09, 2024 |
|
Deep Learning-based Whole-body Prostate-specific Membrane Antigen PET/CT Attenuation Correction
|
May 08, 2024 |
|
Transfected SARS-CoV-2 Spike DNA Suppresses Cancer Cell Response to Chemotherapy
|
May 06, 2024 |
|
Oncotarget Sponsors 19th International p53 Workshop in Italy
|
Apr 29, 2024 |
|
Novel Therapeutic Bispecific Antibodies for B-cell Lymphoma
|
Apr 16, 2024 |
|
Synergistic Effects of Drug Combinations Targeting AML Cells
|
Apr 11, 2024 |
|
Exploring the Role of MIA-602 in Overcoming Doxorubicin-resistance in Acute Myeloid Leukemia
|
Apr 10, 2024 |
|
Identifying Biomarkers for Predicting Paclitaxel Response
|
Mar 28, 2024 |
|
Durvalumab and Tremelimumab Before Surgery in Patients With HR+/HER2-negative Breast Cancer
|
Mar 27, 2024 |
|
ABT199/Venetoclax Synergism With Thiotepa in Acute Myeloid Leukemia (AML) Cells
|
Mar 25, 2024 |
|
Analytical Validation of an Ultra-sensitive Personalized Circulating Tumor DNA Assay: NeXT Personal®
|
Mar 20, 2024 |
|
“From Osimertinib to Preemptive Combinations” by Dr. Blagosklonny
|
Mar 19, 2024 |
|
A New Antibody Capture Method Reveals G-quadruplex Landscape and its Regulation
|
Mar 18, 2024 |
|
Antitumor Effects of Sacituzumab Govitecan Plus Platinum-Based Chemotherapy
|
Mar 14, 2024 |
|
Oncotarget at AACR Annual Meeting 2024
|
Mar 11, 2024 |
|
GZ17-6.02 With Proteasome Inhibitors Kills Multiple Myeloma Cells
|
Mar 06, 2024 |
|
Sacituzumab Govitecan Plus Platinum-based Chemotherapy in Breast, Bladder, and Lung Carcinomas
|
Mar 04, 2024 |
|
BRCA1 and BRCA2 in a Cohort of Ovarian Cancer Patients From the Salento Peninsula
|
Feb 28, 2024 |
|
GZ17-6.02 With Bexarotene Kills Mycosis Fungoides Cells
|
Feb 26, 2024 |
|
Raw Areca Nut Betel Quid Consumption and Esophageal Cancer
|
Feb 22, 2024 |
|
Combining Causal and Correlative Approaches to Discover Response Biomarkers to Paclitaxel
|
Feb 21, 2024 |
|
NTRK Gene Fusion in Thyroid Cancer: A Clinicogenomic Biobank and Record Linkage Study From Finland
|
Feb 19, 2024 |
|
Oncotarget’s Top 10 Papers Published in 2023 (Crossref Data)
|
Feb 15, 2024 |
|
Genetic and Therapeutic Landscapes in Cohort of Pancreatic Cancer Using NGS and Machine Learning
|
Feb 14, 2024 |
|
Differential Expression of Mad2 Gene in Human Esophageal Cancer
|
Feb 12, 2024 |
|
Genetic Alterations in Thyroid Cancer: Resistance to BRAFi and Anaplastic Transformation
|
Feb 08, 2024 |
|
Evaluation of Ruxolitinib, a Janus Kinase Inhibitor, in Multiple Myeloma
|
Feb 07, 2024 |
|
Drug Discovery in Academia; Dumping in the Publication Landfill?
|
Feb 05, 2024 |
|
BCAS1 Defines a Heterogeneous Cell Population in Diffuse Glioma Patients
|
Jan 31, 2024 |
|
Gene Alterations in Thyroid Cancer Mediate Resistance to BRAF Inhibition & Anaplastic Transformation
|
Jan 29, 2024 |
|
New Drug May Boost Effectiveness of Glioblastoma Treatment
|
Jan 25, 2024 |
|
Lazarus Effect in Patient Treated with Osimertinib for NSCLC with Leptomeningeal Disease
|
Jan 24, 2024 |
|
Published in Oncoscience: My Battle with Cancer. Part 1.
|
Jan 23, 2024 |
|
Bone Marrow Adipocytes Provide Early Sign of Progression from MGUS to Multiple Myeloma
|
Jan 22, 2024 |
|
ATR Inhibition Using Gartisertib in Patient-derived Glioblastoma Cell Lines
|
Jan 17, 2024 |
|
Reductive Carboxylation of Glutamine as a Potential Target in AML
|
Jan 16, 2024 |
|
How Osteopontin Stimulates Mitochondrial Biogenesis and Cancer Metastasis
|
Jan 11, 2024 |
|
One More Step Toward Treatment of PARP Inhibitor-resistant Ovarian Cancers
|
Jan 10, 2024 |
|
Transformation-associated Recombination (TAR) Cloning and Its Applications
|
Jan 08, 2024 |
|
Therapeutically Harnessing Cancer Stem Cell-derived Exosomes
|
Jan 03, 2024 |
|
Melatonin in Cancer Therapy: Lessons From 50 Years of Research
|
Dec 29, 2023 |
|
GFH009: A Potent and Highly Selective CDK9 Inhibitor for the Treatment of Hematologic Malignancies
|
Dec 27, 2023 |
|
Management of Refractory or Relapsed Classic Hodgkin Lymphoma in Brazil
|
Dec 21, 2023 |
|
Melatonin and Carcinogenesis in Mice
|
Dec 18, 2023 |
|
Triple Combination Treatment Overcomes Colorectal Cancer Resistance
|
Dec 14, 2023 |
|
Osteopontin Induces Mitochondrial Biogenesis in Deadherent Cancer Cells
|
Dec 14, 2023 |
|
Cytostatic Persister Cancer Cells: Therapeutic Opportunities and Challenges
|
Dec 13, 2023 |
|
Risk Factors for Long-Term Arm Morbidities Following Breast Cancer Treatments: A Systematic Review
|
Dec 11, 2023 |
|
BCMA+ EV Levels Correlate With Myeloma Response to Belantamab-Mafodotin
|
Dec 06, 2023 |
|
Osteopontin Induces Mitochondrial Biogenesis in Deadherent Cancer Cells
|
Dec 04, 2023 |
|
Can Mechanisms of Hair Loss Shed Light on Cancer and Aging?
|
Nov 29, 2023 |
|
The Double-Edge Sword of CRISPR Application for In Vivo Studies
|
Nov 28, 2023 |
|
Targeting Ras with Protein Engineering
|
Nov 28, 2023 |
|
Genetic Predisposition to Early Breast Cancer in Kazakh Women
|
Nov 22, 2023 |
|
Predicting the Functions of Regulatory Genetic Variants Associated with Cancer
|
Nov 20, 2023 |
|
Immunotherapy Response in Primary vs Metastatic Pancreatic Cancer
|
Nov 16, 2023 |
|
The Obesity Paradox: Metformin for Diabetes and Lung Cancer?
|
Nov 15, 2023 |
|
C/EBPβ Helps MYB Maintain the Oncogenic Program of AML Cells
|
Nov 13, 2023 |
|
Combined Inhibition of SHP2 and Mutated RTKs Prevent Adaptive Resistance in Leukemia
|
Nov 08, 2023 |
|
The Role of HER2 Mutant Alleles in Breast Cancer
|
Nov 06, 2023 |
|
p53’s Protective Role in Extrahepatic Biliary Precancerous Lesions
|
Nov 02, 2023 |
|
FAAH Inhibition Ameliorates Murine Breast Cancer
|
Nov 01, 2023 |
|
Neutrophil PAD4 in Cancer, Beyond Promoting NETosis
|
Oct 30, 2023 |
|
Genetic Modifiers of p53 and Their Potential in Breast Cancer Therapies
|
Oct 25, 2023 |
|
Apoptotic Cells May Drive Cell Death in Hair Follicles During Regression Cycle
|
Oct 23, 2023 |
|
How a Metabolic Enzyme Can Trigger Cell Death in Liver Cancer Cells
|
Oct 20, 2023 |
|
GLS2 Shapes Ferroptosis in Hepatocellular Carcinoma
|
Oct 19, 2023 |
|
The Nuclear Envelope and Breast Cancer Metastasis
|
Oct 18, 2023 |
|
GBP3-STING Interaction in Glioblastoma Coordinates Poor Response to Temozolomide
|
Oct 17, 2023 |
|
HER3: A Vital Target in Cancer Treatment
|
Oct 12, 2023 |
|
Suppression of Cancer Stemness & Drug Resistance via BRAF/EGFR/MEK Inhibition in Colorectal Cancer
|
Oct 11, 2023 |
|
STAT3 as a Target in H3K27M-mutant DMGs
|
Oct 09, 2023 |
|
Blog: Genetic Insights into Early Breast Cancer in Kazakhstan
|
Oct 05, 2023 |
|
UGDH in Clinical Oncology and Cancer Biology
|
Oct 04, 2023 |
|
An Ancient Anti-cancer Mechanism: DISE
|
Oct 03, 2023 |
|
Reassessing COVID-19 Precautions in 2023
|
Sep 27, 2023 |
|
Four Novel Receptors May Link Endometrial Cancer to PCOS
|
Sep 25, 2023 |
|
Blog: Targeting Fatty Acid Binding Proteins in Multiple Myeloma
|
Sep 21, 2023 |
|
DPP4 Inhibitors for Target Therapy Resistance in Renal Cell Carcinoma
|
Sep 20, 2023 |
|
Real-Time Live Tissue Sensitivity Assay for Pancreatic Adenocarcinoma
|
Sep 19, 2023 |
|
Systemic Treatment for Brain Metastasis in HER2-Positive Advanced Breast Cancer
|
Sep 13, 2023 |
|
Updates: MET Targeted Therapy for EXON 14 Mutations in Lung Cancer
|
Sep 11, 2023 |
|
Blog: Predicting Functions of Cancer-Associated Genetic Variants
|
Sep 07, 2023 |
|
Subpopulations of AIB1-Expressing Breast Cancer Cells Enable Invasion and Metastasis
|
Sep 06, 2023 |
|
Validation of a Comprehensive Genomic Profiling Assay: NeXT Dx™
|
Aug 30, 2023 |
|
Adopted Neoplastic Cells and the Consequences of Their Existence
|
Aug 29, 2023 |
|
ER Expression Multiclonality in DCIS: Clinical & Future Insights
|
Aug 29, 2023 |
|
Editorial: A Macrophage is a Macrophage is a Macrophage—in Metastasis
|
Aug 23, 2023 |
|
Aggressive Luminal Breast Cancer: Are Cis-Spliced Fusion Proteins Pathological?
|
Aug 22, 2023 |
|
Inhibiting Glutamine Metabolism Impacts Tumor Cells or the Microenvironment?
|
Aug 14, 2023 |
|
Guiding Therapies for HPV Malignancies: Tumor Burden Surrogates
|
Aug 14, 2023 |
|
Blog: Whole-Genome Doubling and Aneuploidy in Human Cancer
|
Aug 10, 2023 |
|
CDK9 Inhibitors: A Promising Combination Partner in Treating Hematological Malignancies
|
Aug 09, 2023 |
|
AGO2 in T-prolymphocytic Leukemia (T-PLL)
|
Aug 07, 2023 |
|
Epigenetically Guided Cancer Therapy: Targeting H3K27me3 Loss in Pediatric Brain Tumors
|
Aug 02, 2023 |
|
Multiclonality of Estrogen Receptor Expression in Ductal Carcinoma in Situ (DCIS)
|
Aug 01, 2023 |
|
Blog: The Obesity Paradox, Metformin and Lung Cancer
|
Jul 26, 2023 |
|
KIAA0930: A Cachexic Phenotype Inducer in Cancer Cells
|
Jul 25, 2023 |
|
A Multiplex Assay to Assess Activated p300/CBP in Circulating Prostate Tumor Cells
|
Jul 22, 2023 |
|
Novel Therapeutic Strategy Against Melanoma: Combined Targeting of Hedgehog Signaling and BRD4
|
Jul 19, 2023 |
|
Case Report: Intrathoracic Synovial Sarcoma with BRAF V600E Mutation
|
Jul 18, 2023 |
|
Targeting Ras in Cancer Therapies: Advances in Protein Engineering
|
Jul 14, 2023 |
|
Cetuximab's Effectiveness and Toxicity in Advanced Cutaneous Squamous Cell Skin Cancer
|
Jul 12, 2023 |
|
Deciphering Progesterone’s Mechanisms of Action in Breast Cancer
|
Jul 10, 2023 |
|
Turning Immunosuppressive Tumors to Immunostimulatory: Nerofe and Doxorubicin's Impact
|
Jul 06, 2023 |
|
ERβ as a Mediator of Estrogen Signaling in Inflammatory Breast Cancer
|
Jul 03, 2023 |
|
Novel GEM Model Unveils PLK1’s Role in Tumorigenesis
|
Jun 30, 2023 |
|
Decoding the Mechanism Behind MCL-1 Inhibitors: A Pathway to Understanding MCL-1 Protein Stability
|
Jun 28, 2023 |
|
DPDT Anticancer Activity in Human Colon Cancer HCT116 Cells
|
Jun 26, 2023 |
|
Targeting GITR in Cancer Immunotherapy – There Is No Perfect Knowledge
|
Jun 21, 2023 |
|
Metformin's Role in Preventing Metabolic Syndrome During Androgen Deprivation Therapy
|
Jun 20, 2023 |
|
Oncotarget Sponsors 2023 Ride for Roswell
|
Jun 19, 2023 |
|
ACSL4: Biomarker, Mediator and Target in Quadruple Negative Breast Cancer
|
Jun 14, 2023 |
|
LP-284 Targets Non-Hodgkin's Lymphoma and DNA Damage Repair Deficiency
|
Jun 12, 2023 |
|
Targeting the Src N-Terminal Regulatory Element in Cancer
|
Jun 09, 2023 |
|
Value of Chemotherapy Post Immunotherapy in Stage IV Non-Small Cell Lung Cancer
|
Jun 07, 2023 |
|
BORIS Gene Mutation and Expression: Link to Breast Cancer Progression
|
Jun 06, 2023 |
|
Deconstructing the Role of MALAT1 in MAPK-Signaling in Melanoma
|
May 30, 2023 |
|
Can the Creatine Shuttle be Targeted to Fight Colorectal Cancer?
|
May 26, 2023 |
|
Behind the Study: Molecular Dialogue Between Tumor Cells and Fibroblasts
|
May 24, 2023 |
|
HER3: Survival Pathway and Therapeutic Target in Metastatic Colorectal and Pancreatic Cancer
|
May 24, 2023 |
|
GPR141 Regulates Breast Cancer Progression via Oncogenic Mediators and the p-mTOR/p53 Axis
|
May 22, 2023 |
|
Targeting Cellular Respiration as a Therapeutic Strategy in Glioblastoma
|
May 19, 2023 |
|
Impact Journals (Oncotarget's Publisher) at SSP 45th Annual Meeting
|
May 17, 2023 |
|
Automated, Accurate Reporting for NGS-Based Clonality Testing
|
May 16, 2023 |
|
Reaching the Brain Through the Groin: A Novel Approach to Brain Cancer
|
May 12, 2023 |
|
Using Cancer Proteomics Data to Identify Gene Candidates for Therapeutic Targeting
|
May 10, 2023 |
|
Role of Biomarkers in Management of Lumps in the Breast
|
May 09, 2023 |
|
LY6 Gene Family: Potential Tumor Antigens and Prognostic Biomarkers in Endometrial Cancer
|
May 08, 2023 |
|
Systemic AL Amyloidosis: Current Approach and Future Direction
|
May 05, 2023 |
|
Retinol Disruption and The Role of Vitamin A Metabolism in Colon Cancer
|
May 03, 2023 |
|
Crossroads: The Role of Biomarkers in the Management of Lumps in the Breast
|
May 02, 2023 |
|
Defining the Complexity of EGFR Endocytosis in Cancer
|
Apr 28, 2023 |
|
Differential Silencing of STAT3 Isoforms Leads to Changes in STAT3 Activation
|
Apr 26, 2023 |
|
Tumor Necroptosis Promotes Metastasis by Modulating Tumor-Host Immunity
|
Apr 24, 2023 |
|
CA 19-9 and CEA in Prognosis of Duodenal Adenocarcinoma: A Retrospective Study
|
Apr 18, 2023 |
|
The Evolution of Metastatic Cancer: Mechanisms and Drivers
|
Apr 17, 2023 |
|
Cancer Prevention with Rapamycin
|
Apr 17, 2023 |
|
Riluzole and Sorafenib in Patients With Advanced Solid Tumors: A Phase I Trial
|
Apr 12, 2023 |
|
Crosstalk Between Triple Negative Breast Cancer and Microenvironment
|
Apr 11, 2023 |
|
Cancer-Associated Fibroblasts: Challenges and Opportunities
|
Apr 07, 2023 |
|
Impact of Cortactin in Cancer Progression
|
Apr 07, 2023 |
|
Oncotarget at AACR Annual Meeting 2023
|
Apr 07, 2023 |
|
Targeting Pre-Leukemic Cells: New Hope for Preventing Childhood B-ALL
|
Mar 31, 2023 |
|
Downregulation of Angulin-1/LSR Induces Malignancy in Lung Adenocarcinoma
|
Mar 30, 2023 |
|
Polyisoprenylated Cysteinyl Amide Inhibitors Deplete G-Proteins in Cancer Cells
|
Mar 28, 2023 |
|
Attenuation of Cancer Proliferation by Suppression of Glypican-1
|
Mar 22, 2023 |
|
Unlocking the Potential of Molecular-Driven Stratification of Osteosarcoma
|
Mar 20, 2023 |
|
Unconventional Protein Secretion (UPS) in Cancer
|
Mar 17, 2023 |
|
MTAP Loss in Metastatic Breast Cancer Patients: Genomic Landscape
|
Mar 14, 2023 |
|
Selective Protection of Normal Cells From Chemotherapy, While Killing Drug-Resistant Cancer Cells
|
Mar 14, 2023 |
|
Mitochondria Engage the Integrated Stress Response to Promote Tumor Growth
|
Mar 08, 2023 |
|
HALP Score: Prognostic Ability in Cancers - A Literature Review
|
Mar 08, 2023 |
|
Unveiling the Non-Canonical Functions of EZH2 in Prostate Cancer
|
Mar 03, 2023 |
|
The Role of Kras and Canonical Wnt Pathways in Biliary Tract Cancers
|
Mar 02, 2023 |
|
WNT-pathway Medulloblastoma: What Constitutes Low-risk and How Low Can One Go?
|
Feb 27, 2023 |
|
Oncogenic Driver FGFR3-TACC3 Requires 5 Coiled-coil Heptads to Activate and Disulfide Bonds
|
Feb 22, 2023 |
|
Oncotarget’s Top 10 Papers In 2022 (Crossref Data)
|
Feb 21, 2023 |
|
Phenotype Approach IDs Rare ATR Variants as Potential Male Breast Cancer Susceptibility Alleles
|
Feb 21, 2023 |
|
Controlling Glycolytic Flux: Therapy Challenges and Solutions
|
Feb 16, 2023 |
|
Novel Prognostic Index to Predict Survival Outcomes in Gastric Cancer Patients
|
Feb 14, 2023 |
|
Everolimus Inhibits Angiogenesis, Lymphangiogenesis in TP53 Mutant HNSCC
|
Feb 09, 2023 |
|
Immunoregulatory Protein CD200 as Potentially Lucrative Yet Elusive Cancer Therapy Target
|
Feb 06, 2023 |
|
The Importance of CD56 in the Fight Against Multiple Myeloma
|
Feb 03, 2023 |
|
Mivavotinib for Relapsed/Refractory B-cell Lymphoma (Updated)
|
Jan 31, 2023 |
|
Intraventricular Immunovirotherapy; A Translational Step Forward
|
Jan 26, 2023 |
|
The Chromatographic Constitution of Andiroba Oil and its Healing Effects…
|
Jan 24, 2023 |
|
Researchers Identify New Drug Candidates To Treat DLST+ Tumors
|
Jan 19, 2023 |
|
Targeting CD74 in B-Cell Non-Hodgkin Lymphoma With Antibody-Drug Conjugate STRO-001
|
Jan 17, 2023 |
|
Calcium Signaling Induced by 15-deoxy-prostamide-J2 Promotes Cell Death by...
|
Jan 12, 2023 |
|
Impact of Covid-19 on Management of Patients With Metastatic Melanoma
|
Jan 11, 2023 |
|
Anti-PD-1 Immune Checkpoint Therapy Resistance, Macrophages and the Wnt Pathway
|
Jan 05, 2023 |
|
Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia
|
Jan 05, 2023 |
|
Serum microRNAs as New Criteria for Referral to Early Palliative Care Services
|
Jan 03, 2023 |
|
Role of Pyrethroid Derivatives in Autophagy and Apoptosis Crosstalk Signaling
|
Jan 03, 2023 |
|
Plasma Growth Hormone in HCC as Biomarker of Response to Atezolizumab & Bevacizumab
|
Dec 22, 2022 |
|
A New Method of Targeting Exosomes in Precision Medicine
|
Dec 21, 2022 |
|
Behind the Study: APOE Genotype Determines Cancer Patients Most Likely to Benefit From Exercise
|
Dec 13, 2022 |
|
Plasma Growth Hormone in HCC: A Biomarker of Response to Atezo/Bev?
|
Dec 09, 2022 |
|
p-STAT3 & c-Myc Correlate With P2-HNF4α Expression in Nonalcoholic Fatty Liver Disease
|
Dec 06, 2022 |
|
Essential Amino Acids as Diagnostic Biomarkers of Hepatocellular Carcinoma
|
Dec 02, 2022 |
|
Myeloid-Derived Suppressor Cells: Cancer, Autoimmune Diseases, and More
|
Nov 29, 2022 |
|
Treasures From Trash In Cancer Research
|
Nov 22, 2022 |
|
APOE Genotype Determines Cancer Patients Most Likely to Benefit From Exercise
|
Nov 22, 2022 |
|
Mutation Analysis of Newly-Diagnosed Germinal Center Aggressive B Cell Lymphomas
|
Nov 17, 2022 |
|
Biomarkers May Predict Neoadjuvant Chemosensitivity in Bladder Cancer
|
Nov 15, 2022 |
|
MK256 a Novel CDK8 Inhibitor With Antitumor Activity in AML Through Downregulation of STAT Pathway
|
Nov 10, 2022 |
|
Press Release: Nectin-4 Widely Expressed in Head and Neck Squamous Cell Carcinoma
|
Nov 02, 2022 |
|
New Target Fights Ferroptosis- and Radio-Resistance in Lung Cancers
|
Nov 02, 2022 |
|
Press Release: Oncotarget Is Again On MEDLINE
|
Oct 27, 2022 |
|
Press Release: Therapeutic Efficacy of H2aL2a, H3L3 in Xenograft Models of Human Breast, Lung Cancer
|
Oct 25, 2022 |
|
Press Release: PDGF Cross-Signaling Indicates Bypassed Signaling in Colorectal Cancer
|
Oct 20, 2022 |
|
Synergy of HDACi, PARPi and Chemotherapeutics Against Blood Cancer
|
Oct 19, 2022 |
|
Press Release: Radiotherapy for Local Control in T3N0 Rectal Cancer
|
Oct 13, 2022 |
|
Press Release: Nutritional Support Attenuates Chemotherapy-Associated Muscle Toxicity
|
Oct 11, 2022 |
|
Trending With Impact: CRISPR Screens Identify Novel Targets for Personalized Cancer Therapy
|
Oct 10, 2022 |
|
Press Release: Genomic Alterations Predictive of Poor Clinical Outcomes in Pan-cancer
|
Oct 04, 2022 |
|
Press Release: HIV/HPV-Related Metastatic Colorectal Cancer Response to Nivolumab
|
Sep 29, 2022 |
|
How High Altitudes Influence HIF-1, Gastric Cancer & Patient Survival
|
Sep 28, 2022 |
|
Trending With Impact: Protein-Based Risk Model Predicts Esophageal Cancer Recurrence
|
Sep 26, 2022 |
|
Press Release: Targeting RCC w/Poly ADP-ribose Polymerase Inhibitors, Low-dose Alkylating Chemo
|
Sep 20, 2022 |
|
Behind the Study: Inhibition of Resistant Triple-negative Breast Cancer Cells
|
Sep 19, 2022 |
|
Press Release: An ABC Transporter as a Potential Target Against SHH-Medulloblastoma
|
Sep 15, 2022 |
|
Behind the Study: Targeting Lipid Metabolism in Treatment of Ovarian Cancer
|
Sep 12, 2022 |
|
Press Release: Imaging With Polypeptide Fusion Protein Targets Bladder Cancer
|
Sep 08, 2022 |
|
Immunotherapy Response Predicted By Machine Learning & Gut Microbiomes
|
Sep 01, 2022 |
|
Epigenetics and Immunotherapy Combined Fights Rare Lymphoma
|
Aug 24, 2022 |
|
Press Release: Kinase Activity in RCC, Renal Tissue and in Response to TKI
|
Aug 17, 2022 |
|
Glypican-3 (GPC3) Associated With MCPyV-negative Status and Impaired Outcome in MCC
|
Aug 11, 2022 |
|
Press Release: Novel Regulatory Mechanism of GLI3 by Toll-like Receptor Signaling
|
Aug 09, 2022 |
|
Does a Mechanism Linking Cellular Aging to Cellular Quiescence Exist?
|
Aug 08, 2022 |
|
Press Release: Chemoradiation Alters PD-L1, CD8+ TILs and Mucin in Rectal Cancer
|
Aug 02, 2022 |
|
Press Release: CUDC907 Promotes Apoptosis Of NF2 Schwannoma Cells
|
Jul 26, 2022 |
|
Predicting Cancer Immunotherapy Response From Gut Microbiomes Using Machine Learning Models
|
Jul 20, 2022 |
|
How Heartburn Can Turn Into Esophageal Cancer, and a Possible Biomarker
|
Jul 15, 2022 |
|
Behind the Study: Molecular Characterization of Lung Carcinomas Expressing KK-LC-1
|
Jul 11, 2022 |
|
Role Of Germline Variants In The Metastasis Of Breast Carcinomas
|
Jul 07, 2022 |
|
Press Release: Continuous Treatment With Abemaciclib and Breast Cancer Cell Proliferation
|
Jul 06, 2022 |
|
Genes & Cancer: How Ewing Sarcoma Led to Discoveries in Rhabdomyosarcoma
|
Jun 29, 2022 |
|
Press Release: New Oncology-Focused Papers Published in Volume 13
|
Jun 23, 2022 |
|
Press Release: Genes & Cancer | Now on PubMed: Volume 12
|
Jun 17, 2022 |
|
Press Release: Impact Journals Sponsors 2022 Ride for Roswell
|
Jun 15, 2022 |
|
Behind the Study: IGF-pathway Biomarkers and Lung Cancer
|
Jun 14, 2022 |
|
Press Release: Group of Genes That Cause Endocrine Resistance in Breast Cancer Identified ...
|
Jun 08, 2022 |
|
Paper Spotlight: Tool Uses NF-κB Activity to Classify HPV+ Head and Neck Cancer
|
May 26, 2022 |
|
Press Release: NF-κB Over-Activation Portends Improved Outcomes in HPV+ HNSCC
|
May 25, 2022 |
|
Press Release: Anti-Cancer Drug Profiling With CancerOmicsNet
|
May 20, 2022 |
|
Trending With Impact: Dual Requirement in Stem Cell Leukemia/Lymphoma
|
May 18, 2022 |
|
Press Release: Impact Journals at SSP Annual Meeting
|
May 18, 2022 |
|
Paper Spotlight: Gene Variants Investigated in Polish Bladder and Kidney Cancer
|
Apr 28, 2022 |
|
Trending With Impact: Analysis of Mutational Burden in NSCLC
|
Apr 26, 2022 |
|
Press Release: Mutational Burden in Lung Cancer Studied in Multisite Cohort
|
Apr 26, 2022 |
|
Author Insight: How ONC201 Kills Breast Cancer Cells
|
Apr 22, 2022 |
|
Trending With Impact: Genes Identified in Endocrine Therapy Resistance
|
Apr 15, 2022 |
|
Author Insight: Secretomes from Metastatic Breast Cancer Cells and MSC Actions
|
Apr 14, 2022 |
|
Paper Spotlight: Novel Therapeutic Strategies Against Endometrial Cancer
|
Apr 07, 2022 |
|
Author Insight: Down Syndrome iPSC Model: Endothelial Perspective on Tumor Development
|
Mar 31, 2022 |
|
Announcement: Impact Journals at AACR Annual Meeting 2022
|
Mar 28, 2022 |
|
Trending With Impact: Interrelated Oncogenic Pathways in Osteosarcoma
|
Mar 25, 2022 |
|
Trending With Impact: Adjunct Virotherapy Fights Multiple Myeloma
|
Mar 18, 2022 |
|
Paper Spotlight: Remote Weight Loss Strategy for Breast Cancer Survivors
|
Mar 10, 2022 |
|
Trending With Impact: Are NOTCH1 Variants Prognostic in Breast Cancer?
|
Feb 24, 2022 |
|
Author Insight: Mitigating Radiation for Space Colonization
|
Feb 23, 2022 |
|
Author Insight: Potential Protective Mechanism Against UVB Exposure
|
Feb 21, 2022 |
|
Trending With Impact: New Pre-Transplant AML Treatment Combinations
|
Feb 18, 2022 |
|
Author Insight: Cancer Drug Prices in Low- and Middle-Income Countries
|
Feb 15, 2022 |
|
Paper Spotlight: Iron Chelators in Cancer Treatment
|
Feb 10, 2022 |
|
Author Insight: Precision Oncology Improves Patient Survival, Financial Burdens
|
Feb 08, 2022 |
|
Paper Spotlight: Prognostic Markers Identified in Ultra-Rare Adrenal Cancer
|
Feb 02, 2022 |
|
Trending With Impact: What Causes Chemo Brain?
|
Feb 02, 2022 |
|
Role of Cancer Associated Fibroblasts in Prostate Cancer
|
Jan 27, 2022 |
|
Oncotarget’s Top-10 Most-Viewed Papers in 2021
|
Jan 21, 2022 |
|
Rare Incidence of Type 1 Diabetes Induced by Immunotherapy
|
Jan 18, 2022 |
|
Microbial Metabolite Mimicry May Improve Drug Discovery
|
Jan 17, 2022 |
|
Gene Mutations and Neoantigens in Head and Neck Tumors
|
Jan 14, 2022 |
|
Announcement: Open-Access Oncotarget Shifts to Continuous Publishing
|
Jan 06, 2022 |
|
New Study: Biomarkers Linked to the Progression of Endometrial Cancer
|
Dec 24, 2021 |
|
Functional Inhibitor Compounds Inhibit Herpes Simplex Virus Proliferation
|
Dec 23, 2021 |
|
Unique Biomarker Analysis & Interpretation Platform in Clinical Decision-making
|
Dec 22, 2021 |
|
Genomic and Neoantigen Evolution in Head and Neck Squamous Cell Carcinoma
|
Dec 21, 2021 |
|
Lung Cancer Antigen Expression Characterized by Molecular Subtype
|
Dec 09, 2021 |
|
Table of Contents: Volume 12, Issue #25
|
Dec 07, 2021 |
|
Zebrafish B Cell Acute Lymphoblastic Leukemia: New Findings in Old Model
|
Dec 02, 2021 |
|
CrkL Required for Donor T Cell Migration to GvHD Target Organs
|
Dec 02, 2021 |
|
Exploratory Study of Metformin and Rapamycin as Maintenance Therapy
|
Dec 01, 2021 |
|
Innovating & Expanding Weight Loss Strategies for Breast Cancer Survivors
|
Nov 30, 2021 |
|
Reversing Oncogenic Transformation With Iron Chelation
|
Nov 26, 2021 |
|
GATA3 and APOBEC3B are Prognostic Markers in Adrenocortical Carcinoma
|
Nov 25, 2021 |
|
New Study: Investigation of Colorectal Cancer-Promoting Protein
|
Nov 24, 2021 |
|
Table of Contents: Volume 12, Issue #24
|
Nov 23, 2021 |
|
Sunscreen Chemical Promotes Breast Cancer in Diet-Dependent Manner
|
Nov 18, 2021 |
|
Prolyl 4-hydroxylase Alpha 1 Protein Expression Risk-stratifies Early Stage Colorectal Cancer
|
Nov 16, 2021 |
|
Consuming Cholera Toxin Counteracts Age-associated Obesity
|
Nov 12, 2021 |
|
New Study: ALK Rearrangement Among Lung Cancer Patients
|
Nov 11, 2021 |
|
Table of Contents: Volume 12, Issue #23
|
Nov 11, 2021 |
|
Bacterial Therapy Experiments in Prostate Cancer
|
Nov 03, 2021 |
|
Benzophenone-3 Promotion of Mammary Tumorigenesis is Diet-dependent
|
Nov 02, 2021 |
|
New Study: Vaccine Enhances Breast Cancer Treatment
|
Oct 28, 2021 |
|
Table of Contents: Volume 12, Issue #22
|
Oct 28, 2021 |